Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce bloody diarrhea, fatigue, bloody stool, chronic fatigue, and/or liver disease associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children to join a Crohn’s disease clinical trial to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or Crohn’s disease (including associated symptoms such as recurrent diarrhea, diarrhea, constant need to poop, chronic fatigue and/or anemia), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce diarrhea with blood and pus, weight loss, bloody stool, malnutrition, and/or eye pain associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

Is your child currently experiencing IBD flare-ups? Local clinical research is testing a potential new medication to see if it may reduce abdominal cramps, failure to thrive, cramps, weight loss, and/or anemia associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce long-term diarrhea, unexplained weight loss, abdominal pain, frequent fevers, and/or eye pain associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children 2–17 years old to join a Crohn’s disease (CD) trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or ulcerative colitis (including associated symptoms such as bloody diarrhea, persistent diarrhea, abdominal pain, frequent fevers and/or anemia), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

We are looking for 2–17 year olds to join a Crohn’s disease clinical research to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or CD (including associated symptoms such as bloody diarrhea, unexplained weight loss, constant need to poop, chronic fatigue and/or joint pain), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

We are looking for 2 to 17 years of age to join a Crohn’s disease (CD) medical research study to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s and UC (including associated symptoms such as joint pain, fistula, cramps, weight loss and/or joint pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

We are looking for young people 2–17 years old to join a Crohn’s disease clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s disease (including associated symptoms such as cramping, mouth sores, constant need to poop, chronic fatigue and/or anemia), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

We are looking for children at least 2 years of age but under 18 to join a CD study to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or moderate to severe ulcerative colitis (including associated symptoms such as abdominal cramping, inflammation of the bowel or intestine, rectal pain, chronic fatigue and/or liver disease), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.